Cargando…

The Effect of Anti‐Scl‐70 Antibody Determination Method on Its Predictive Significance for Interstitial Lung Disease Progression in Systemic Sclerosis

OBJECTIVE: The objective of this study was to assess the predictive significance of anti‐Scl‐70 (anti‐topoisomerase I) antibodies, as determined by three different methods, for decline in forced vital capacity (FVC) within the first year of follow‐up in patients with systemic sclerosis (SSc)‐related...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jandali, Bochra, Salazar, Gloria A., Hudson, Marie, Fritzler, Marvin J., Lyons, Marka A., Estrada‐Y‐Martin, Rosa M., Charles, Julio, Terracina, Katherine A., Mayes, Maureen D., Assassi, Shervin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals, Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992461/ https://www.ncbi.nlm.nih.gov/pubmed/35048554 http://dx.doi.org/10.1002/acr2.11398

Ejemplares similares

Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort
por: Assassi, Shervin, et al.
Publicado: (2010)

The changing landscape of the clinical value of the PM/Scl autoantibody system
por: Mahler, Michael, et al.
Publicado: (2009)

Peripheral blood gene expression profiling shows predictive significance for response to mycophenolate in systemic sclerosis-related interstitial lung disease
por: Assassi, Shervin, et al.
Publicado: (2022)

Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen
por: Mahler, Michael, et al.
Publicado: (2005)

Oral manifestations of Systemic Sclerosis and Correlation with anti-Topoisomerase I Antibodies (SCL-70)
por: Bajraktari, Ismet H., et al.
Publicado: (2015)

Enrichment Strategy for Systemic Sclerosis Clinical Trials Targeting Skin Fibrosis: A Prospective, Multiethnic Cohort Study
por: Mihai, Carina, et al.
Publicado: (2020)

Proteomic aptamer analysis reveals serum markers that characterize preclinical systemic sclerosis (SSc) patients at risk for progression toward definite SSc
por: Bellocchi, Chiara, et al.
Publicado: (2023)

Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease
por: Volkmann, Elizabeth R., et al.
Publicado: (2016)

Genetic susceptibility loci of idiopathic interstitial pneumonia do not represent risk for systemic sclerosis: a case control study in Caucasian patients
por: Wu, Minghua, et al.
Publicado: (2016)

Reactome pathway analysis from whole-blood transcriptome reveals unique characteristics of systemic sclerosis patients at the preclinical stage
por: Bellocchi, Chiara, et al.
Publicado: (2023)

Clinical evaluation of CENP-B and Scl-70 autoantibodies in silicosis patients
por: Lee, Suni, et al.
Publicado: (2017)

Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations
por: Hoa, S., et al.
Publicado: (2016)

Understanding diagnostic pathways in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: A retrospective cohort study
por: Assassi, Shervin, et al.
Publicado: (2022)

Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients
por: Hanke, Katharina, et al.
Publicado: (2009)

Genetics of scleroderma: implications for personalized medicine?
por: Assassi, Shervin, et al.
Publicado: (2013)

Osteopontin in Systemic Sclerosis and its Role in Dermal Fibrosis
por: Wu, Minghua, et al.
Publicado: (2012)

Right Bundle Branch Block: A Predictor of Mortality in Early Systemic Sclerosis
por: Draeger, Hilda T., et al.
Publicado: (2013)

Correction: Right Bundle Branch Block: A Predictor of Mortality in Early Systemic Sclerosis
por: Draeger, Hilda T., et al.
Publicado: (2014)

The Role of Type 1 Interferon in Systemic Sclerosis
por: Wu, Minghua, et al.
Publicado: (2013)

A Rare Case Report of Acquired Bartters With Positive Anti Scl70 Antibody
por: Pande, Arunkumar Ramanarth, et al.
Publicado: (2021)

Anti Scl-70 Antibody Positive Systemic Sclerosis in a Patient with Lung Cancer: A Paraneoplastic or a Purely Coincidental Phenomenon?
por: Gangopadhyay, Anusree, et al.
Publicado: (2013)

Multiomic study of skin, peripheral blood, and serum: is serum proteome a reflection of disease process at the end-organ level in systemic sclerosis?
por: Farutin, Victor, et al.
Publicado: (2021)

Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations
por: Gourh, Pravitt, et al.
Publicado: (2009)

Predictors of progression in systemic sclerosis patients with interstitial lung disease
por: Distler, Oliver, et al.
Publicado: (2020)

Predictors of Fatigue Severity in Early Systemic Sclerosis: A Prospective Longitudinal Study of the GENISOS Cohort
por: Assassi, Shervin, et al.
Publicado: (2011)

Scleroderma Renal Crisis in a Systemic Sclerosis With Anti-PM/Scl Antibodies
por: Jacquier, Marine, et al.
Publicado: (2019)

Circulating cytokine levels in systemic sclerosis related interstitial lung disease and idiopathic pulmonary fibrosis
por: Zheng, Boyang, et al.
Publicado: (2023)

Contribution of HLA and KIR Alleles to Systemic Sclerosis Susceptibility and Immunological and Clinical Disease Subtypes
por: Hanson, Aimee L., et al.
Publicado: (2022)

Energy upgrade of the EHF SCL
por: Vretenar, Maurizio, et al.
Publicado: (1987)

SCL chips in for Big Bang
por: Singh Nibber, Gurpreet
Publicado: (2005)

Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis
por: Gourh, Pravitt, et al.
Publicado: (2010)

Anti-PM/Scl Antibody-positive Systemic Sclerosis Complicated by Multiple Organ Involvement
por: Shimizu, Tatsuya, et al.
Publicado: (2020)

Autoantibodies in Systemic Sclerosis: Unanswered Questions
por: Kayser, Cristiane, et al.
Publicado: (2015)

Anti-HMGCR antibodies in systemic sclerosis
por: Hudson, Marie, et al.
Publicado: (2016)

Interstitial Lung Disease Is a Major Characteristic of Patients Who Test Positive for Anti-PM/Scl Antibody
por: Ge, Yongpeng, et al.
Publicado: (2022)

Wong-type dermatomyositis with interstitial lung disease and anti-SRP and -PM/Scl antibodies treated with intravenous immunoglobulin
por: Kowalski, Eric H., et al.
Publicado: (2023)

Do anti-DFS70 antibodies temper disease activity and progression in SLE?
por: Choi, May Y, et al.
Publicado: (2021)

Skin involvement in early diffuse cutaneous systemic sclerosis: an unmet clinical need
por: Herrick, Ariane L., et al.
Publicado: (2022)

Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression
por: Khanna, Dinesh, et al.
Publicado: (2023)

The Role of SCL Isoforms in Embryonic Hematopoiesis
por: Chuang, Chin-Kai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5uk927eln6bva5jqtqfcvlqp1s